国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

   

Study tests hepatitis B vaccine

(Xinhua)
Updated: 2006-10-26 08:39

A second phase of clinical tests of China's hepatitis B vaccine are being carried out on 46 chronic hepatitis B patients to test the vaccine's effectiveness, said expert Wu Yuzhang.

The patients began treatment in June and will remain under close medical observation until the tests end next March, said Wu, head of the Immunology Institute of the People's Liberation Army.

The research team headed by Wu completed the first phase of clinical tests of the vaccine in June 2003. Nine months of monitoring found no safety concerns on a group of 52 healthy volunteers.

"The vaccine needs to go through a third phase of clinical tests before being put into production. The third phase of tests will be conducted on a larger group of hepatitis B patients to test safety and effectiveness," Wu said.

It is estimated that about 100 million Chinese are living with hepatitis B and about 20 million of them are chronic hepatitis B patients. Each year in China about 280,000 people die of cirrhosis or liver cancer linked to hepatitis B.

Wu said the hepatitis B global inoculation scheme being promoted by the World Health Organization is based on a preventive vaccine, which has no effect on infected people and fails to protect five to 15 percent of newborns.

The Chinese Foundation for Hepatitis Prevention and Control has invited Andy Lau, a famous Hong Kong star, who is carrying the hepatitis B virus, to be a publicity ambassador for the prevention and control of the disease.

The Chinese Ministry of Health has begun a yearlong nationwide survey of hepatitis B, to update guidelines on prevention and control of the disease.

On another liver virus, officials are calling hepatitis C a major public health threat in China. Health departments must do more to raise public awareness of the disease, an expert said in Beijing yesterday.

Hepatitis C is a serious threat to health in China and a public health challenge for the government, said Zhuang Hui, director of the Society of Hepatitis Diseases, attached to the Chinese Medical Association.

He called for the more active measures to prevent the disease and to monitor high risk groups such as medical workers, intravenous drug users, people with multiple sex partners and those who have received blood transfusions or organ transplants.

According to the national Center for Disease Control and Prevention, 40 million Chinese are carrying the hepatitis C virus. New infection cases jumped to about 60,000 in 2005 from 20,000 in 2003. Although acute symptoms are relatively mild compared with other types of hepatitis, it tends to become chronic and can develop into cirrhosis and liver cancer.


 
 

辉南县| 鄄城县| 凌海市| 甘泉县| 孟村| 汉寿县| 依安县| 芷江| 浏阳市| 手游| 桃源县| 长治县| 正阳县| 奎屯市| 滕州市| 塔城市| 交城县| 南康市| 肇庆市| 化隆| 阜新市| 龙南县| 沈丘县| 丰原市| 平泉县| 望奎县| 明溪县| 丹棱县| 汶川县| 鲁甸县| 剑河县| 阜新| 荃湾区| 高邑县| 宝坻区| 穆棱市| 泰来县| 曲阳县| 大宁县| 扎兰屯市| 集贤县|